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Abstract
Objective: The evolution toward more stringent conceptualizations of remission in
family therapy for adolescent anorexia nervosa (AN) has, with time, introduced vari-
ability in outcomes across randomized controlled trials (RCTs). An examination of
remission across the history of research on family therapy for AN shows that earlier
studies adopted lenient definitions and generally yielded higher rates of remission
than studies of the past decade that have used stricter definitions of remission. In
this study, we investigate the reactivity of remission rates to the application of differ-
ent definitions of remission used within the family therapy for AN literature, within a
single RCT data set.
Method: We conducted a secondary analysis of data from a single-site RCT which
compared the relative efficacy of two formats of family therapy in a sample of
106 Australian adolescents with AN. Using end-of-treatment data, we compared
remission rates using 11 definitions of remission that have been used in studies of
family therapy for AN spanning more than three decades.
Results: We found wide variability in remission rates (21.7–87.7%; Cochran's Q
χ2(10, N = 106) = 303.55, p = .000], depending on which definition of remission was
applied. As expected, more lenient criteria produced higher remission rates than more
stringent definitions.
Discussion: Applying different criteria of remission to a single data set illustrates the
impact of changing how remission is defined. Failure to consider the greater stringency
of remission criteria in recent studies could result in false inferences concerning the
efficacy of family therapy for AN over time.
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1 | INTRODUCTION
For more than 50 years, anorexia nervosa (AN) has been the focus of
a series of family therapy interventions designed to facilitate remis-
sion by targeting family-level processes. Family-based treatment (FBT;
Lock & Le Grange, 2013) is an intervention that is currently consid-
ered the first-line treatment for medically stable adolescents with AN
(National Institute for Health and Care Excellence [NICE], 2017). The
treatment outcome literature on FBT has recently been synthesized in
both a meta-analysis and comprehensive review (Couturier, Kimber, &
Szatmari, 2013; Lock & Le Grange, 2019), each illustrating the relative
efficacy of FBT compared to other psychological interventions for eat-
ing disorders in children and adolescents. Notably, there was marked
variability across these studies in the outcome variables used to test
the efficacy of FBT. In this article, we examine rates of remission across
the history of research on family therapy for AN (i.e., within-treatment
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TABLE 1 Definitions and rates of remission at end-of-treatment and follow-up in randomized clinical trials of family interventions for
adolescent anorexia nervosa
Study Sample characteristics Definition of remission Treatment component % remitted
Russell et al., 1987 & Eisler
et al., 1997
N = 10a
100% female
12–18 years
<3 years duration AN
“Good” or “intermediate”Morgan
Russell Scale (MRS)
Family therapy (FT) 90
FT (5 years) 90
Le Grange, Eisler, Dare, &
Russell, 1992
N = 18
89% female
12–17 years
<3 years duration AN
“Good” or “intermediate”MRS FT or family counseling (FC) 67
Robin et al., 1999 N = 19
100% female
11–20 years
Attainment of target weight
established by pediatrician
Behavioral family systems therapy
(BFST)
67
BFST (12 months) 80
25th percentile of body mass
index (BMI) for age
BFST 84
BFST (12 months) 87
50th percentile of BMI for age BFST 53
BFST (12 months) 67
Eisler et al., 2000 & Eisler,
Simic, Russell, & Dare,
2007
N = 40
98% female
11–17 years
“Good” or “intermediate”MRS Conjoint FT 47
Conjoint FT (5 years) 78
Separated FT 76
Separated FT (5 years) 90
Ball & Mitchell, 2004b N = 12
100% female
12–23 years
AN <90% average body weight
“Good” or “intermediate”MRS,
modified to include a minimum
weight gain of 4 kg and body
weight within 10% of 50th
percentile of BMI
Family-based treatment (FBT) 58
FBT (6 months) 58
Lock, Agras, Bryson, &
Kraemer, 2005 & Lock,
Couturier, & Agras, 2006
N = 86
90% female
12–18 years
BMI > 17.5 FBT, short or long-term 96
BMI > 20 and Eating Disorder
Examination (EDE) within 2 SDs
of community norms
FBT, short or long-term 67
>90% IBW FBT, short or long-term (4 years) 89
EDE within adult community
norms
FBT, short or long-term (4 years) 74
Lock et al., 2010 & Le
Grange et al., 2014
N = 61
89% female
12–18 years
≥95% expected body weight
(EBW) and EDE global within
1 SD of community norms
FBT 43
FBT (4 years) 28
Agras et al., 2014 N = 78
86% female
12–18 years
≥95% EBW FBT 33
FBT (12 months) 41
Madden, Miskovic-
Wheatley, Wallis, Kohn,
Lock, et al., 2015b
N = 82
95% female
12–18 years
>95% EBW and EDE global within
1 SD of community norms
Medical stabilization (MS), then
FBT
25
MS, then FBT (12 months) 30
Weight restoration (WR), then FBT 21
WR, then FBT (12 months) 33
Lock et al., 2015 N = 45
91% female
12–18 years
≥95% EBW FBT 63
FBT without intensive parental
Counseling (IPC)
48
FBT with IPC 58
Eisler et al., 2016 N = 169
91% female
13–20 years
“Good” or “intermediate”MRS FT 58
FT (6 months) 57
Multifamily FT 76
Multifamily FT (6 months) 78
(Continues)
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change), rather than in contrast to other interventions. We also investi-
gate the reactivity of remission rates to the application of various defi-
nitions of remission that have been used to delineate treatment
response in FBT research.
Early treatment studies (Eisler et al., 2000; Russell, Szmukler, Dare, &
Eisler, 1987) defined outcomes primarily as a function of weight status.
Embedded within the psychopathology of AN, emaciation represents a
cardinal sign of illness. Low body weight is clinically significant in its own
right and often portends an array of medical complications, including car-
diac abnormalities and amenorrhea (Mehler & Brown, 2015); it is also
an obstacle to change and a driver of cognitive symptoms, that is, fear
of weight gain, drive for thinness (Accurso, Ciao, Fitzsimmons-Craft,
Lock, & Le Grange, 2014). Reversing the state of starvation is there-
fore a priority in any intervention for AN. To this end, weight mea-
surements are a key indicator of treatment response, even when
cognitive remission lags behind physical remission (Murray, Quintana,
Loeb, Griffiths, & Le Grange, 2019). Moreover, weight measures have
the added benefit of being relatively objective in comparison to the
self-reported cognitive features of AN, particularly for adolescents
(Bravender et al., 2010).
Despite the importance of weight-based outcomes, this narrow
measure has been reconsidered over time within wider questioning in
the field regarding how to optimally operationalize AN recovery, a
construct that goes beyond remission in scope and duration
(Bardone-Cone et al., 2010; Couturier & Lock, 2006a; Dawson,
Rhodes, & Touyz, 2015). Given the fragility of partial clinical improve-
ment (Khalsa, Portnoff, McCurdy-McKinnon, & Feusner, 2017), and
the high risk of chronicity in AN (Eddy et al., 2017; Fichter, Quadflieg,
Crosby, & Koch, 2017; Herpertz-Dahlmann et al., 2018), it has been
argued that the bar for clinical efficacy in AN RCTs should be set high.
In this earnest effort, aptly highlighted by Bardone-Cone, Hunt, and
Watson (2018), the broader eating disorder community is urged to
reach consensus on how to define recovery, and that this definition
includes at least three key criteria; physical, behavioral, and psycho-
logical well-being. Presently, however, there is still no consensus as to
precisely what constitutes clinically significant change over a course of
treatment for AN.
2 | DEFINITIONS AND RATES OF
REMISSION IN FAMILY INTERVENTIONS
FOR AN
Fourteen RCTs of family therapy for adolescent AN and four corres-
ponding longer-term follow-up studies have been published to date. This
includes the earliest trials of family therapy for adolescent AN (FT-AN)
from which FBT derives (Lock & Le Grange, 2013). Table 1 summarizes
the definitions and rates of remission described in each of these studies,
apart from two in which remission rates were not reported as outcomes
(Geist, Heinmaa, Stephens, Davis, & Katzman, 2000; Lock, Fitzpatrick,
Agras, Weinbach, & Jo, 2018). Across these studies, rates of remission at
end-of-treatment and follow-up varied from 21% to 96%. Notably, remis-
sion rates in earlier studies (1987–2006) ranged from 47% to 96%, while
remission rates from the past decade (2010–2016) have ranged from
21% to 78%. This raises the possibility that more recent studies have less
positive results.
In studies of FT-AN, remission was measured with the Morgan-
Russell outcome scale, a semistructured interview that assesses
weight, menstrual status, mental status, psychosocial and psychosex-
ual development, as well as binge eating or purging behavior. Cogni-
tive symptoms are not directly evaluated. “Good” plus “intermediate”
outcomes are considered to be treatment success as compared to
“poor” outcome (Morgan & Hayward, 1988; Morgan & Russell, 1975;
Russell et al., 1987). Applying this scale in a somewhat redacted for-
mat, patients achieve “good” outcome when they maintain their
weight above 85% mBMIa (median body mass index), have no binge
eating or purging behavior, and menstruate (for postmenarchal
females). “Intermediate” outcome involves the same weight criterion,
but patients are either not menstruating or experiencing bulimic
symptoms on an average of less than once per week over the past
month. Patients are described as having “poor” outcome when their
TABLE 1 (Continued)
Study Sample characteristics Definition of remission Treatment component % remitted
Le Grange et al., 2016 N = 107
88% female
12–18 years
≥95% mBMI and EDE global
within 1 SD of community
norms
Parent focused therapy (PFT) 43
PFT (12 months) 37
FBT 22
FBT (12 months) 29
Note. For studies reporting multiple follow-up time points, final row represents last reported follow-up. Data represent the most complete remission rates
reported in each study (see original articles for calculation details). AN, anorexia nervosa; MRS, Morgan Russell Scale; FT, family therapy; FC, family
counseling; BFST, behavioral family systems therapy; kg, kilograms; BMI, body mass index; FBT, family-based treatment; IBW, ideal body weight; EDE,
Eating Disorder Examination; mBMI, median body mass index; SD, standard deviation; EBW, expected body weight; MS, inpatient medical stabilization;
WR, inpatient weight restoration; IPC, intensive parental coaching; PFT, parent-focused treatment.
aThis report describes the stratified subgroup of AN with onset before 18 years of age and duration of illness less than 3 years, which yielded a primarily
adolescent sample (M = 16.6 years old, SD = 1.7). Other AN subgroups in this study extended to older individuals (Subgroup 2 M = 20.6 years old, SD = 4.0;
Subgroup 3 M = 27.7 years old, SD = 7.8) by virtue of age of onset and/or duration of illness. Please see original study for further details.
bAlthough the original study did not report the frequency or percent remitted, these data were later reported in a meta-analysis (Couturier et al., 2013).
a. The preferred terms used to define and describe weight status within the ED field have
changed over time, previously including ideal and expected body weight (IBW and EBW,
respectively). Currently, percent median body mass index (% mBMI) is the recommended
standard, and is calculated as (current BMI/50th percentile BMI for age and sex) ×
100 (Golden, Katzman, Sawyer, & Ornstein, 2015).
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weight is less than 85% mBMI or they experience more frequent
bulimic symptoms. Thus, using the Morgan Russell Scale, allows one
to meet criteria for remission (i.e., “good” + “intermediate” outcome)
by having a body weight ≥85% mBMI with bulimic symptoms occur-
ring on average less than once per week over the past month.
Studies using the Morgan-Russell scale have reported remission
rates ranging from 47% to 90% (Ball & Mitchell, 2004; Eisler et al.,
1997; Eisler et al., 2000; Eisler et al., 2007; Eisler et al., 2016; Le
Grange et al., 1992; Russell et al., 1987). Likewise, other early studies
(Lock et al., 2005; Robin et al., 1999) placed an emphasis on weight res-
toration, yet defined remission using relatively low body mass index
(BMI) or BMI percentile cutoffs (e.g., BMI > 17.5, BMI ≥ 25th percentile
for ageb). Such operational definitions do not set high expectations for
remission, as patients can be considered remitted despite relatively low
weight, the presence of broader disordered eating behaviors (i.e., bulimic
symptoms), and the persistence of cognitive AN psychopathology
(i.e., ongoing fear of weight gain, drive for thinness).
Recent studies have used more rigorous definitions of remission.
First, the more conservative threshold of ≥95% mBMI is now commonly
used to delineate weight restoration (Agras et al., 2014; Le Grange et al.,
2014; Le Grange et al., 2016; Lock et al., 2010; Lock et al., 2015;
Madden, Miskovic-Wheatley, Wallis, Kohn, Lock, et al., 2015b), given
evidence that this threshold best predicts longer-term recovery for ado-
lescents with AN (Accurso et al., 2014; Lock et al., 2013). In FBT studies
using this higher threshold, reported rates of remission range from 33%
to 63% (Agras et al., 2014; Lock et al., 2015). Second, beginning with
Lock et al. (2005), studies have frequently incorporated the Eating Disor-
der Examination (EDE) (Fairburn, Cooper, & O'Connor, 2014) to assess
change of cognitive and behavioral symptoms of AN over the course of
FBT. Although the EDE assesses frequency of bulimic symptoms, these
particular behavioral data are not incorporated in the EDE Global score.
In combining weight and cognitive symptoms, remission has been
defined as ≥95% mBMI plus EDE Global score within one standard devi-
ation (SD) of community norms (≤1.59) (Fairburn & Beglin, 1994). Lock
and Le Grange were the first to employ this combined criterion set in a
multisite RCT that compared FBT to adolescent-focused individual ther-
apy (Lock et al., 2010). When using this strict definition of combined
weight and cognitive remission, rates of remission in studies of FBT have
ranged from 21% to 43% (Le Grange et al., 2014; Le Grange et al., 2016;
Lock et al., 2010; Madden, Miskovic-Wheatley, Wallis, Kohn, Lock, et al.,
2015b). A similar definition that uses the same weight cutoff, but an EDE
global score within 2 SDs of community norms (≤2.52), has been applied in
some studies (Lock, Couturier, Bryson, & Agras, 2006; Madden, Miskovic-
Wheatley, Wallis, Kohn, Hay, et al., 2015a). However, this definition has
not been reported as amain outcome in randomized studies of FBT.
An early study by Couturier and Lock (2006b) applied various defini-
tions from a broad body of adult and adolescent AN literature to a FBT
RCT data set, illustrating their respective impact on remission. Since that
paper was published, the number of FBT RCTs has doubled, bringing
with it additional criteria sets for remission. For instance, in one later
RCT (Madden, Miskovic-Wheatley, Wallis, Kohn, Hay, et al., 2015a), the
authors demonstrated outcome variability as a function of two different
definitions of remission. However, no study to date has applied the full
range of definitions of remission from three decades of FBT RCT litera-
ture to one recent FBT RCT sample. Elucidating definitional shifts in
FBT-AN outcomes, and the corresponding implications for interpreting
the past and recent FBT literature, would promote transparency around
the evidence-base for this intervention. It may also help establish future
research priorities, such as a more direct, rapid, and targeted amelioration
of cognitive symptoms in parallel to weight restoration (Murray et al.,
2019; Murray, Loeb, & Le Grange, 2018).
The evolving definition of remission is one factor that has poten-
tially contributed to the wide variability in remission rates reported
across studies of family therapy, with an apparent trend toward
declining outcomes over the past 30 years. To formally investigate
the reactivity of remission rates to various definitions of remission
used in the AN family therapy literature, we conducted a secondary
analysis of an RCT that compared two formats of FBT (Le Grange
et al., 2016). Specifically, the present study aimed to explicate if and
how the definition of remission affects reported outcomes, a crucial
endeavor in parsing out the efficacy of this intervention across its his-
tory. We hypothesized there would be significant variability in the
derived remission rates, with definitions using weight only, low weight
thresholds and/or no amelioration of cognitive or behavioral symp-
toms, yielding higher remission rates compared to definitions requiring
higher thresholds on these parameters.
3 | METHOD
Data for this secondary analysis were derived from a single-site RCT
from Melbourne, Australia which compared the relative efficacy of
conjoint FBT and parent-focused treatment (PFT), a separated-format
variant of FBT (Le Grange et al., 2016). The data that support the find-
ings of this study are available from the corresponding author upon
reasonable request. For the purpose of this analysis, we combined the
full sample of the RCT rather than separating the two conditions. Spe-
cifically, conjoint FBT and PFT are variants of the same core interven-
tion; our goal was not to parse out differential responses to treatment
among the multiple versions of family therapy for AN, nor to perform
a reanalysis of the primary outcome in the main study hypotheses.
Participants were 106 adolescents (M = 15.5, SD = 1.5) who met a
DSM-IV diagnosis of AN with two modifications in alignment with the
proposed diagnostic criteria for AN within DSM-5, which had an antici-
pated publication timeline during the course of this RCT. As reported in
the main outcome manuscript (Le Grange et al., 2016), the study did
not apply the amenorrhea criterion and applied greater flexibility in
operationalizing low weight status, that is, ≤90% mBMI for adolescents
≤75th percentile for height, and <95% mBMI for adolescents ≥75th
percentile for height. At baseline, participants' mean %mBMI was 81.9
(SD = 6.1), and mean duration of illness was 10.5 months (SD = 8.8, range
2–48 months). There were no significant baseline differences between
b. BMI percentile for age was calculated using the standardized growth charts available at
that time (US Department of Health, Education, and Welfare, 1973).
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treatment groups; detailed demographic and clinical characteristics have
been reported elsewhere (Le Grange et al., 2016).
Using end-of-treatment data from this RCT, we recalculated
remission rates for the entire study sample using the definitions com-
monly reported in all prior studies of FT-AN and FBT across the past
30 years. Based on this literature, remission was evaluated with
11 definitions, summarized in Table 2. In the RCT data set (used in the
current analysis), for cases where there were missing EDE data at end-
of-treatment (N = 13), the imputed value for the EDE Global score based
upon multiple imputation (c.f., Le Grange et al., 2016) was applied in
determining remission status. Because the Morgan Russell Scale was not
administered to the Melbourne data set, we reconstructed this scale's
remission criteria from extracted items on the EDE. In the event that
bulimic symptom data were missing (N = 12), a conservative approach
was taken and the participant was considered not remitted. Variability in
rates of remission across definitions was tested using the nonparametric
Cochran's Q test for related samples.
4 | RESULTS
In calculating data for these 106 adolescents using BMI and BMI per-
centile cutoffs from the extant literature reviewed, the following
remission rates were obtained: 76.4% (81) for BMI > 17.5, 59.4%
(63) for BMI ≥ 25th percentile for age, and 21.7% (23) for BMI ≥ 50th
percentile for age. Using varying %mBMI cutoffs, the following
remission rates were generated: 75.5% (80) at ≥85% mBMI, 61.3%
(65) at ≥90% mBMI, and 42.5% (45) at ≥95% mBMI. Applying the
Morgan Russell Scale produced a remission rate of 58.5% (62 of 106);
excluding those with missing bulimic symptom data produced a remis-
sion rate of 66% (62 of 94)c (see Figure 1).
When remission was defined in the 106 cases using EDE Global
scores alone, the following remission rates were obtained: 87.7% at
EDE Global within 2 SDs of community norms, and 77.4% at EDE
Global within 1 SD of community norms. Combining weight status
with the EDE yielded the following rates of remission: 37.7% ≥ 95%
mBMI plus EDE Global within 2 SDs of norms, and 32.1% ≥ 95%
mBMI plus EDE Global within 1 SD of norms. Cochran's Q test for
related samples was significant [χ2(10, N = 106) = 303.55, p = .000].
5 | DISCUSSION
Exploring the reactivity of remission rates to the application of various
criteria that have been used to define treatment response in AN family
treatment research confirmed a broad range of statistically distinct remis-
sion rates within a single data set. These outcomes can be consolidated
into three categories. First, when the definition of remission incorporated
only weight status, with the threshold set low (e.g., BMI > 17.5 or ≥85%
mBMI), or only cognitive remission, as represented by an EDE Global
score within one or two SDs of community norms, remission was
achieved by a majority of patients (>75% on average). Second, when the
weight threshold was set higher (e.g., BMI ≥ 25th percentile, or at least
90%mBMI), or using the Morgan Russell Scale “good” plus “intermediate”
categories, the remission rate was approximately 60%. The third defini-
tion used a high weight threshold with a BMI > 50th percentile, or mini-
mum 95%mBMI, or the latter weight threshold with the EDE Global
score within one or two SDs of community norms, but did not include
behavioral criteria (i.e., binge eating/purging). Remission was achieved in
about one third of patients. The RCT from which these secondary ana-
lyses were undertaken applied this latter definition of remission and cor-
respondingly found that about one third of patients achieved remission
at end-of-treatment (Le Grange et al., 2016). The consequence of chang-
ing the definition of remission is clearly demonstrated; if any of the first
definition criteria were applied to this RCT sample, remission rates would
have appeared similar to those in the earlier family therapy studies
(e.g., Eisler et al., 2000; Russell et al., 1987). Or to put it slightly differ-
ently, remission rates in the most recently published RCT for family ther-
apy would have been above 80%, that is, identical to that in the seminal
study published in 1987 (Russell et al., 1987). While implications of vari-
able definitions of remission for research are apparent, implications for
clinical care are also clear. For example, if clinicians decide to terminate
treatment of adolescents with AN based only on when these patients
meet remission criteria that sets a low bar (e.g., low weight cutoff),
TABLE 2 Definitions of remission and results of these definitions
applied to data from a clinical trial of two interventions for anorexia
nervosa
Definition of remission
Results
(% remitted)
per definition
1. BMI > 17.5 76
2. BMI ≥ 25th percentile for agea 59
3. BMI ≥ 50th percentile for age 22
4. ≥85% mBMI with bulimic symptoms
occurring less than once per week over
the past month (equivalent of “good” or
“intermediate”MRS)
59
5. ≥85% mBMI 76
6. ≥90% mBMI 61
7. ≥95% mBMI 43
8. EDE global within 2 SDs of norms 88
9. EDE global within 1 SD of norms 77
10. ≥95% mBMI plus EDE global within 2 SDs
of norms
38
11. ≥95% mBMI plus EDE global within 1 SD of
norms
32
Note. BMI, body mass index; EDE, Eating Disorder Examination; MRS,
Morgan Russell Scale.
aBMI percentiles were calculated using the Centers for Disease Control
and Prevention for age and gender formula, available at https://nccd.cdc.
gov/dnpabmi/calculator.aspx.
c. Of 106 participants, 13 were missing each of the bulimic symptom items on the EDE
(e.g., frequency of objective binging, self-induced vomiting, laxative misuse, and driven
exercise). Of those 13:1 was also missing weight, 5 were below 85% mBMI, and 7 were
above 85% mBMI. Hypothetically, if each of these 7 individuals did not have bulimic
symptoms, 65% of the sample would have been considered remitted.
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discharge from care could be premature and put their patients at greater
risk of relapse.
Our results, together with those of Couturier and Lock (2006b)
and Madden, Miskovic-Wheatley, Wallis, Kohn, Hay, et al. (2015a),
illustrate that stricter definitions of remission are generally associated
with lower remission rates. The evolution toward conceptualizations
of outcomes of FBT where thresholds are high is a positive trend as it
ensures that treatment efficacy is not overstated. Certainly, if one
accepts the notion that cognitive factors propel the weight loss charac-
teristic of AN, then determining remission as a function of both cogni-
tive and weight-related symptoms is necessary. However, the evolution
of the conceptualization of treatment outcomes, by definition, has
introduced variability in the intervention over time and across RCTs,
regardless of other changes. As a result, outcomes in FBT could appear
to be worsening over time—under the assumption of an “apples to
apples” rather than “apples to oranges” set of comparisons—even as
manualization and implementation of this treatment have been consid-
erably refined during this period (Couturier & Kimber, 2015; Lock & Le
Grange, 2013). As such, the risk is that treatment efficacy may be
understated when higher thresholds for remission are applied. This is
particularly significant as newer adaptations of FBT (e.g., varying deliv-
ery format) that utilize outcome criteria that include both weight and
cognitive recovery are being carefully scrutinized for their efficacy.
Understanding the implications of different definitions of remission are
critical to ensure that appropriate comparisons are made. A failure to
consider the greater stringency of these later remission criteria could
result in false inferences concerning the execution and efficacy of fam-
ily therapy over time and across investigators.
Our study raises at least two questions for consideration: (a) do
the findings challenge the purported efficacy of FBT, and (b) can these
findings inform consensus on a core outcome set for eating disorders,
as promulgated by the COMET initiative (Core Outcome Measures in
Effectiveness Trials—(http://www.comet-initiative.org)? In addressing
the first questions, it is important to note that the current study was
not designed to empirically identify the best measure of efficacy of
FBT, or directly address the efficacy of FBT. That said, our findings
help explain, rather than challenge the purported efficacy of FBT.
Going forward, there is a need for research which examines the reli-
ability, construct validity, and predictive validity of the various defini-
tions of remission to inform such recommendations (c.f., Lock et al.,
2013; Madden, Miskovic-Wheatley, Wallis, Kohn, Hay, et al., 2015a).
This would in turn assist in addressing the second question, which is
to consider what constitutes the core outcome definition, as endorsed
by COMET, that should be reported for future efficacy trials in adoles-
cent AN. We not only argue for agreement in the field for a uniform
approach to reporting remission, but also advocate for a definition of
remission that, at a minimum, should strive to set the bar for (a) weight
status at a level that would support growth, bone health, hormonal
functioning, and cognitive development in adolescents (e.g., ≥95%
mBMI), and (b) eating- and body-related cognitive, as well as
(c) behavioral status at levels that reflect normal development
(e.g., EDE Global Score within 1 SD of the community norm and an
absence of binge eating or purging). Venturing to suggest a defini-
tion of remission that can be applied transdiagnostically and across
age groups, while much needed, is outside the scope of this
manuscript.
Findings from the current study offer important insights into
the potential challenges of between-trial comparisons across stud-
ies which utilize different conceptualizations of outcomes in the
treatment of AN. Appropriate attention to such detail is urged
whether interpreting individual study results or findings across the
AN treatment literature, or when utilizing such information to
inform clinical care. Our findings also have implications for the
broader eating disorder treatment outcome literature in that there
are as many definitions of remission as there are published studies,
regardless of diagnosis (Bardone-Cone et al., 2018). Gaining con-
sensus in this broader field about the definition of remission is of
critical importance in prospectively creating a cohesive storyline as
this body of research evolves.
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